News

Insight into Options Market Movements for Celsius Holdings

Insight into Options Market Movements for Celsius Holdings

Understanding Options Market Dynamics for Celsius Holdings

Investors are collectively leaning towards a bullish outlook on Celsius Holdings (CELH), signaling confidence among significant market players.

This observation stems from recent trading activity, revealing traders with substantial capital engaging in large options trades.

While it's unclear if these activities originate from institutional investors or affluent individuals, the presence of such large trades often indicates that key players anticipate significant price movements for CELH in the near future.

Recent data from options activity shows a notable imbalance in trader sentiment. Today, the options scanner identified several unusual trades for Celsius Holdings, highlighting a trend among large-money investors.

Analysis of the transaction patterns shows that traders are bullish, with a strong majority expressing optimism about the stock's future. In particular, 66% of the trades indicate a bullish sentiment, while 22% lean bearish.

Projected Price Range for Celsius Holdings

The analysis of options trading reveals that key investors are targeting a price range between $15.00 and $40.00 for Celsius Holdings in the upcoming months. This extensive territory reflects their expectations and strategic planning regarding the company's stock movement.

Volume and Open Interest Assessment

In options trading, understanding volume and open interest is crucial for gauging market liquidity and investor engagement in particular options. The following insights outline the fluctuations in trading metrics associated with Celsius Holdings over the last 30 days, focusing on both call and put options across a spectrum of strike prices.

Recent Activity Summary for Celsius Holdings

Analyzing the options landscape reveals several significant transactions involving Celsius Holdings. Here’s a summary of the most notable trades over the past month:

  • Trade: CALL | Type: SWEEP | Sentiment: BULLISH | Expiration Date: 01/16/26 | Total Price: $164.7K | Strike Price: $40.00
  • Trade: CALL | Type: SWEEP | Sentiment: BULLISH | Expiration Date: 01/16/26 | Total Price: $156.2K | Strike Price: $36.67
  • Trade: CALL | Type: TRADE | Sentiment: NEUTRAL | Expiration Date: 07/18/25 | Total Price: $147.5K | Strike Price: $15.00
  • Trade: PUT | Type: SWEEP | Sentiment: BEARISH | Expiration Date: 03/21/25 | Total Price: $93.7K | Strike Price: $37.50
  • Trade: CALL | Type: SWEEP | Sentiment: BULLISH | Expiration Date: 09/19/25 | Total Price: $65.8K | Strike Price: $27.50

About Celsius Holdings

Celsius Holdings operates within the energy drink sector of the nonalcoholic beverage industry, with a disportionate percentage of its revenue generated from North America. The company features a product lineup rich in natural ingredients and designed to enhance metabolism, making it a preferred choice for fitness enthusiasts and active individuals.

Their offerings include Celsius Originals beverages, Celsius Essentials line, which incorporates amino acids, and easy-to-carry Celsius On-the-Go powder packets. The company emphasizes innovation and branding, while partnering with external parties for manufacturing, packaging, and distribution. In a pivotal move, Celsius secured a long-term distribution agreement with PepsiCo, which now holds a significant ownership stake.

An in-depth review of the options activity for Celsius Holdings encourages a closer look at the company's market presence and performance metrics.

Celsius Holdings' Current Market Position

  • The stock is presently trading at $28.41, reflecting an increase of 2.53% with a trading volume of 3,116,776 shares.
  • Current RSI (Relative Strength Index) suggests that the stock is balanced, positioned neither in an overbought nor an oversold state.
  • The next anticipated earnings announcement is about 98 days away, which could further influence investor decisions.

Expert Opinions on Celsius Holdings' Future

Insights from five professional analysts over the last month set an optimistic average price target of $44.20 for the stock. Their evaluations include:

  • An analyst from B. Riley Securities maintains a Buy rating, targeting $44.
  • Roth MKM's analyst supports a Buy rating, setting a target at $40.
  • UBS's analyst continues with a Buy rating, forecasting a $45 target price.
  • Stifel analysts also agree with a Buy rating, with the same target of $45.
  • B. Riley Securities has updated their target price to $47 while retaining a Buy rating.

As options trading can carry substantial risks alongside potential gains, savvy traders are encouraged to continuously educate themselves, adapt their strategies, and closely monitor market trends. Keeping abreast of the latest options activity around Celsius Holdings can provide a strategic edge.

Frequently Asked Questions

What does bullish sentiment mean in options trading?

Bullish sentiment indicates that traders expect the price of a stock to rise, influencing their decision to purchase call options.

How does open interest affect options trading?

Open interest represents the total number of outstanding options contracts, reflecting market activity and trader interest in specific strike prices.

What is the significance of RSI in stock analysis?

RSI, or Relative Strength Index, is used to identify overbought or oversold conditions in a stock, aiding investors in making informed trading decisions.

How can I stay updated on Celsius Holdings' performance?

Regularly check financial news platforms, trading apps, and market analysis websites for the latest insights on Celsius Holdings.

What should I consider before trading options?

Before trading options, consider your risk tolerance, investment goals, and the need for a well-researched strategy to navigate the markets effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading